Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Cameron

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|March 18, 2020
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumorsAung Naing, Justin F Gainor, Hans Gelderblom, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 24, 2024
Developing and disseminating an electronic penicillin allergy de-labelling tool using the model for improvement frameworkSujen Saravanabavan, Patrick McKernan, Scott Cameron, et al.
Scientific Reports|October 30, 2015
Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and functionChristian Barucker, Heiko J Bittner, Philip K-Y Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2018
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant TrialAditya Bardia, Marina Parton, Sherko Kümmel, et al.
Brain, Behavior, and Immunity|April 27, 2020
Baseline immunoreactivity before pregnancy and poly(I:C) dose combine to dictate susceptibility and resilience of offspring to maternal immune activationMyka L Estes, Kathryn Prendergast, Jeremy A MacMahon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Lori J Wirth, Thomas Ernst, et al.
Elife|March 5, 2021
Sequential perturbations to mouse corticogenesis following in utero maternal immune activationCesar P Canales, Myka L Estes, Karol Cichewicz, et al.
Nucleic Acids Research|June 26, 2003
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteinsPål Puntervoll, Rune Linding, Christine Gemünd, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 7, 2025
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus projectVishal Avinashi, Milli Gupta, Beth A Payne, et al.
Journal of the Canadian Association of Gastroenterology|December 15, 2025
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus projectVishal Avinashi, Milli Gupta, Beth A Payne, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|March 18, 2020
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumorsAung Naing, Justin F Gainor, Hans Gelderblom, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 24, 2024
Developing and disseminating an electronic penicillin allergy de-labelling tool using the model for improvement frameworkSujen Saravanabavan, Patrick McKernan, Scott Cameron, et al.
Scientific Reports|October 30, 2015
Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and functionChristian Barucker, Heiko J Bittner, Philip K-Y Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2018
Paclitaxel With Inhibitor of Apoptosis Antagonist, LCL161, for Localized Triple-Negative Breast Cancer, Prospectively Stratified by Gene Signature in a Biomarker-Driven Neoadjuvant TrialAditya Bardia, Marina Parton, Sherko Kümmel, et al.
Brain, Behavior, and Immunity|April 27, 2020
Baseline immunoreactivity before pregnancy and poly(I:C) dose combine to dictate susceptibility and resilience of offspring to maternal immune activationMyka L Estes, Kathryn Prendergast, Jeremy A MacMahon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
PD-1 Blockade in Anaplastic Thyroid CarcinomaJaume Capdevila, Lori J Wirth, Thomas Ernst, et al.
Elife|March 5, 2021
Sequential perturbations to mouse corticogenesis following in utero maternal immune activationCesar P Canales, Myka L Estes, Karol Cichewicz, et al.
Nucleic Acids Research|June 26, 2003
ELM server: A new resource for investigating short functional sites in modular eukaryotic proteinsPål Puntervoll, Rune Linding, Christine Gemünd, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|November 7, 2025
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus projectVishal Avinashi, Milli Gupta, Beth A Payne, et al.
Journal of the Canadian Association of Gastroenterology|December 15, 2025
Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus projectVishal Avinashi, Milli Gupta, Beth A Payne, et al.
Pageof 12